Modeling hypercalciuria in the genetic hypercalciuric stone-forming rat
Authors:
- Kevin K. FrickKFKevin K. Frick
- Nancy S. KriegerNKNancy S. Krieger
- David A. BushinskyDBDavid A. Bushinsky
- 1 June 2015
- journal article
- review article
- Published by Wolters Kluwer Health in Current Opinion in Nephrology and Hypertension
- Vol. 24 (4) , 336-44
Abstract
In this review, we discuss how the genetic hypercalciuric stone-forming (GHS) rats, which closely model idiopathic hypercalciuria and stone formation in humans, provide insights into the pathophysiology and consequences of clinical hypercalciuria. Hypercalciuria in the GHS rats is due to a systemic dysregulation of calcium transport, as manifest by increased intestinal calcium absorption, increased bone resorption and decreased renal tubule calcium reabsorption. Increased levels of vitamin D receptor in intestine, bone and kidney appear to mediate these changes. The excess receptors are biologically active and increase tissue sensitivity to exogenous vitamin D. Bones of GHS rats have decreased bone mineral density (BMD) as compared with Sprague-Dawley rats, and exogenous 1,25(OH)2D3 exacerbates the loss of BMD. Thiazide diuretics improve the BMD in GHS rats. Studying GHS rats allows direct investigation of the effects of alterations in diet and utilization of pharmacologic therapy on hypercalciuria, urine supersaturation, stone formation and bone quality in ways that are not possible in humans.Keywords
This publication has 71 references indexed in Scilit:
- Epigenetic Regulation of BMP2 by 1,25-dihydroxyvitamin D3 through DNA Methylation and Histone ModificationPLOS ONE, 2013
- Nephrolithiasis-associated bone disease: pathogenesis and treatment optionsKidney International, 2011
- Calcium Kidney StonesNew England Journal of Medicine, 2010
- Elevated vitamin D receptor levels in genetic hypercalciuric stone-forming rats are associated with downregulation of SnailJournal of Bone and Mineral Research, 2010
- Genetic Hypercalciuric Stone-Forming Rats Have a Primary Decrease in BMD and StrengthJournal of Bone and Mineral Research, 2009
- Thiosulfate Reduces Calcium Phosphate NephrolithiasisJournal of the American Society of Nephrology, 2009
- Prevention of recurrent calcium nephrolithiasisNephrology, 2007
- Genetic HypercalciuriaJournal of the American Society of Nephrology, 2005
- Thiazides Reduce Brushite, but not Calcium Oxalate, Supersaturation, and Stone Formation in Genetic Hypercalciuric Stone–Forming RatsJournal of the American Society of Nephrology, 2005
- Increased dietary oxalate does not increase urinary calcium oxalate saturation in hypercalciuric ratsKidney International, 1999